UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 144

Sortiert nach

Angiogenin: a review of the pathophysiology and potential clinical applications

Journal of thrombosis and haemostasis, 2006-09, Vol.4 (9), p.1864-1874

2006

Volltextzugriff (PDF)

New perspectives in antiplatelet therapy

Current medicinal chemistry, 2012, Vol.19 (3), p.406

2012

Volltextzugriff (PDF)

Interleukin-6 as a predictor of cardiovascular events in troponin-negative non-ST elevation acute coronary syndrome patients

International journal of clinical practice (Esher), 2014-03, Vol.68 (3), p.294-303

2014

Volltextzugriff (PDF)

Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets

Nutrition, metabolism, and cardiovascular diseases, 2024-01, Vol.34 (1), p.90-97

2024

Volltextzugriff (PDF)

Respuesta al ECG de julio de 2015

Revista española de cardiologia, 2015-08, Vol.68 (8), p.718-718

Tello-Montoliu, Antonio

2015

Volltextzugriff (PDF)

ECG de julio de 2015

Revista española de cardiologia, 2015-07, Vol.68 (7), p.627-627

Tello-Montoliu, Antonio

2015

Volltextzugriff (PDF)

On the Way to a Better Use of Anticoagulants in Nonvalvular Atrial Fibrillation. Proposed Amendment to the Therapeutic Positioning Report UT/V4/23122013

Revista española de cardiología (English ed.), 2016-06, Vol.69 (6), p.551-553

2016

Volltextzugriff (PDF)

Haemostatic profiles assessed by thromboelastography in patients with end-stage renal disease

Thrombosis and haemostasis, 2011-07, Vol.106 (1), p.67

2011

Volltextzugriff (PDF)

Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease

Thrombosis and haemostasis, 2014-02, Vol.111 (2), p.258

2014

Volltextzugriff (PDF)

Functional profile of the platelet P2Y₁₂ receptor signalling pathway in patients with type 2 diabetes mellitus and coronary artery disease

Thrombosis and haemostasis, 2011-04, Vol.105 (4), p.730

2011

Volltextzugriff (PDF)

Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus

Thrombosis and haemostasis, 2012-11, Vol.108 (5), p.930

2012

Volltextzugriff (PDF)

Plasma angiogenin levels in acute coronary syndromes: implications for prognosis

European heart journal, 2007-12, Vol.28 (24), p.3006-3011

2007

Volltextzugriff (PDF)

The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage?

Heart (British Cardiac Society), 2010-02, Vol.96 (3), p.227-228

2010

Volltextzugriff (PDF)

P5656Heart failure clinical phenotypes and outcomes in patients with atrial fibrillation: an analysis from the eurobservational research programme in atrial fibrillation long-term general registry

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

Is “one size fits all” anti-aggregation really effective? Variability in the response to P2Y12 receptor inhibitors in obese patients

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Comentarios a la guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular

Revista española de cardiologia, 2017, Vol.70 (1), p.2-8

2017

Volltextzugriff (PDF)

P565A 5-item simplified Geleijnse score has higher predictive ability for identifying the coronary origin of the chest pain

European heart journal, 2018-08, Vol.39 (suppl_1)

2018

Volltextzugriff (PDF)

P3446Regional variation in quality of anticoagulation control among european patients with atrial fibrillation: the EORP-AF general long-term registry

European heart journal, 2018-08, Vol.39 (suppl_1)

2018

Volltextzugriff (PDF)

255Impact of the type of acute coronary syndrome on the pharmocodynamic response to P2Y12 inhibitors in the acute and maintenance phase of therapy

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

Impact of smoking habit on platelet reactivity in a cohort of patients admitted due to an acute coronary syndrome

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

3271Role of a rapid point-of-care platelet function test on bleeding risk prediction in patients undergoing coronary artery bypass grafting surgery

European heart journal, 2018-08, Vol.39 (suppl_1)

2018

Volltextzugriff (PDF)

P3840Impact of potent P2Y12 inhibitors in adverse events reduction in diabetic patients with Acute Coronary Syndromes. An analysis from ACHILLES Registry

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

P3842One-year efficacy and safety of prasugrel and ticagrelor in patients with Acute Coronary Syndromes: results from a prospective and multicenter ACHILLES Registry

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

P939Cardiovascular outcomes in patients with Acute Coronary Syndrome and previous cardiovascular disease. An analysis from ACHILLES Registry

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

P3692Underuse of prasugrel and ticagrelor in patients with chronic kidney disease despite achieving a more effective platelet inhibition than clopidogrel

European heart journal, 2017-08, Vol.38 (suppl_1)

2017

Volltextzugriff (PDF)

1 – 25 von 144

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(131)

Publikationsform

Artikel
(143)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(74)
Science & Technology
(74)
Humans
(62)
Cardiovascular System & Cardiology
(61)
Cardiac & Cardiovascular Systems
(52)
Male
(39)
Female
(38)
Aged
(30)
Middle Aged
(30)
Prospective Studies
(25)
Cardiovascular
(22)
Cardiology
(21)
Ticlopidine - Analogs & Derivatives
(18)
Coronary Artery Disease - Drug Therapy
(17)
Internal Medicine
(17)
Platelet Aggregation Inhibitors - Therapeutic Use
(17)
Treatment Outcome
(17)
Blood Platelets - Drug Effects
(16)
Clopidogrel
(16)
Peripheral Vascular Disease
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Angiogenin: a review of the pathophysiology and potential clinical applications

New perspectives in antiplatelet therapy

Interleukin-6 as a predictor of cardiovascular events in troponin-negative non-ST elevation acute coronary syndrome patients

Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets

Respuesta al ECG de julio de 2015

ECG de julio de 2015

On the Way to a Better Use of Anticoagulants in Nonvalvular Atrial Fibrillation. Proposed Amendment to the Therapeutic Positioning Report UT/V4/23122013

Haemostatic profiles assessed by thromboelastography in patients with end-stage renal disease

Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease

Functional profile of the platelet P2Y₁₂ receptor signalling pathway in patients with type 2 diabetes mellitus and coronary artery disease

Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus

Plasma angiogenin levels in acute coronary syndromes: implications for prognosis

The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage?

P5656Heart failure clinical phenotypes and outcomes in patients with atrial fibrillation: an analysis from the eurobservational research programme in atrial fibrillation long-term general registry

Is “one size fits all” anti-aggregation really effective? Variability in the response to P2Y12 receptor inhibitors in obese patients

Comentarios a la guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular

P565A 5-item simplified Geleijnse score has higher predictive ability for identifying the coronary origin of the chest pain

P3446Regional variation in quality of anticoagulation control among european patients with atrial fibrillation: the EORP-AF general long-term registry

255Impact of the type of acute coronary syndrome on the pharmocodynamic response to P2Y12 inhibitors in the acute and maintenance phase of therapy

Impact of smoking habit on platelet reactivity in a cohort of patients admitted due to an acute coronary syndrome

3271Role of a rapid point-of-care platelet function test on bleeding risk prediction in patients undergoing coronary artery bypass grafting surgery

P3840Impact of potent P2Y12 inhibitors in adverse events reduction in diabetic patients with Acute Coronary Syndromes. An analysis from ACHILLES Registry

P3842One-year efficacy and safety of prasugrel and ticagrelor in patients with Acute Coronary Syndromes: results from a prospective and multicenter ACHILLES Registry

P939Cardiovascular outcomes in patients with Acute Coronary Syndrome and previous cardiovascular disease. An analysis from ACHILLES Registry

P3692Underuse of prasugrel and ticagrelor in patients with chronic kidney disease despite achieving a more effective platelet inhibition than clopidogrel

Suchergebnisse filtern